Amanote Research
Register
Sign In
Pcn224 - Towards Clinical Adoption of Repurposed Drugs in Oncology: Overcoming Regulatory and Market Access Barriers in Europe
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.306
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C. Verbaanderd
I. Rooman
L. Meheus
I. Huys
Publisher
Elsevier BV
Related search
Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Overcoming Barriers to Healthcare Access and Delivery
EAI Endorsed Transactions on Pervasive Health and Technology
Computer Science
Health Informatics
Pin115 - Barriers to Access and Implementation of Rotavirus Vaccination in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Global Health and Emergency Care: Overcoming Clinical Research Barriers
Academic Emergency Medicine
Medicine
Emergency Medicine
Biosimilars: Barriers and Opportunities to Market Access in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs as Cancer Therapeutics
Frontiers in Oncology
Cancer Research
Oncology
PHP89 Market Access of Drugs in France: Evolution or Revolution?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas With Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit
Cancer Cell
Cancer Research
Oncology
Cell Biology
Overcoming Barriers for the Wide-Scale Adoption of Standardized Real-Time Transit Information
